Forj Medical Opens Advanced Device Manufacturing Hub
Tacares de Grecia, Alajuela, Costa Rica – December 9, 2025 – Forj Medical, the newly formed CDMO created by...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease solid tumors targeted therapy
Tacares de Grecia, Alajuela, Costa Rica – December 9, 2025 – Forj Medical, the newly formed CDMO created by...
Ravensburg, Germany — December 3, 2025 — Vetter Pharma-Fertigung GmbH & Co. KG, a global contract development and manufacturing...
Laupheim and Martinsried, Germany, December 2, 2025 — Rentschler Biopharma, a global contract development and manufacturing organization, and Coriolis...
Dateline – Mumbai, India, November 5, 2025:Piramal Pharma Limited (NSE: PPLPHARMA, BSE: 543635), a leading global pharmaceutical, health and...
Eindhoven, Netherlands, November 3, 2025 — Medical-device CDMO VIVOLTA has signed a long-term agreement for a dedicated production facility...
COLUMBIA, S.C., October 30, 2025 — The Ritedose Corporation has received U.S. Food and Drug Administration (FDA) approval to...
Vancouver, British Columbia & Rehovot, Israel — October 30, 2025 — BioHarvest Sciences Inc. (NASDAQ: BHST) has announced a...
OKLAHOMA CITY, Sept. 17, 2025 – Wheeler Bio, Inc., a U.S.-based contract development and manufacturing organization (CDMO), announced today...
Andelyn Biosciences, a leading cell and gene therapy CDMO, has partnered with Tern Therapeutics to perform late-stage Process Performance...
